openPR Logo
Press release

Blepharitis Market Projected to be Resilient During 2017 - 2025

02-02-2018 10:37 AM CET | Health & Medicine

Press release from: Persistence Market Research

Blepharitis Market Projected to be Resilient During 2017 - 2025

Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly at the base of the eye lashes. A dysfunction of the oil glands in eye lid due to hormone imbalance leads to blepharitis. Burning of the eye, sensitivity to light, blurred vision, dry eyes and crusting of eyelashes are some of the common symptoms observed in the patient suffering from blepharitis.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/20932

Blepharitis can be classified as below:

By Types
Anterior Blepharitis, Posterior Blepharitis

Self-care is one of the important treatment option for blepharitis, warm soak of eye lids or eyelid scrub are some of the regular options available for maintaining the hygiene level of eye. Currently, there are no therapeutic treatment options available for blepharitis, many of the key players are engaged in developing drugs that are currently in clinical trial phases. Thus, development and introduction of these new drugs would help to overcome the disease condition. Hence, increasing awareness, introduction of novel drugs and changing lifestyle are some of the key factors driving the growth of these diseases globally.

Geographically, North America and Europe dominates the global blepharitis therapeutics market owing to rising healthcare awareness and increasing disposable income in these regions. In addition, Asia-Pacific region is expected to grow at the highest CAGR due to increasing healthcare awareness and huge untapped customer in this region.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/20932

The overall blepharitis market comprises manufacturers such as Merck & Co., Gelderma S.A., Novartis AG, Lux Biosciences, Inc., InSite Vision Incorporated, Foamix, Ltd., LABORATORIES THEA, Kala Pharmaceuticals among others.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Blepharitis Market Projected to be Resilient During 2017 - 2025 here

News-ID: 928437 • Views: 357

More Releases from Persistence Market Research

The Castleman Disease Treatment market to exhilarate from 2017 to 2025
Castleman disease is a rare condition of lymph nodes and similar tissues. This condition occurs when too many non-cancer cells started to grow in the lymph node. After initial growth hard growth started to form. Usually, it occurs in the chest, abdomen or neck. This condition is also called as angiofollicular lymph node hyperplasia. There are no known risk factors for castleman disease, but it usually occur in adults with
The Infantile And Juvenile Onset Hypophosphatasia Treatment market to invigorate …
The Hypophosphatasia (HPP) is a rare genetic disease caused by mutations in the ALPL gene. It is a metabolic disorder that effects multiple body systems and leads to life-threatening complications. This disease leads to abnormal development of the bones due to defective bone mineralization and can lead to rickets, tempering of the bones that result in different types of bone abnormalities. The sign and symptoms include soft bones, hypercalcemia, short
The C Reactive Protein Test market to witness explicit growth from 2017 and 2025
C-reactive protein test is used to test the level of C-reactive protein (CRP) concentration in the blood. C-reactive protein test is adopted to check for infections or any other medical conditions, and increases in cases of inflammation. C-reactive protein test is conducted in order to evaluate the chances of developing cardiovascular diseases such as coronary artery diseases, which further can lead to severe heart attack. It is believed that increased
The Adventitious Agent Testing market to be in conjunction to growth from 2017 t …
Adventitious agents are microorganisms that have unintentionally introduced into the manufacturing of biological products. They mainly include fungi, mycoplasmas, rickettsia, protozoa, bacteria, parasites, and viruses. Adventitious agents testing is a process of detection by a combination of methods at various stages of biologics production. Adventitious agents are a major concern while using mammalian cell lines for the production of biologics. They are two types of testing methods namely Specific and

All 5 Releases


More Releases for Blepharitis

Blepharitis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results
Blepharitis is an inflammatory disorder of eyelids and can be categorized into two types; anterior and posterior blepharitis. The inflammation at the outside front of the eyelid is anterior blepharitis, whereas, inflammation at the inner eyelid is posterior blepharitis. Download the sample report @ https://www.pharmaproff.com/request-sample/1055 The major complications associated with blepharitis are the sty (acute infection of oil glands in eye), chalazion (painless lump due to inflammation of oil glands in eye),
Blepharitis Market Competitive Healthcare Assessment 2018 to 2025
Global Blepharitis Market Research Report 2018 tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Blepharitis market. This research report offers in-depth analysis of the market size (revenue), market share, major market segments, and different
Blepharitis Treatment Market Trends, Outlook, and Opportunity Analysis, 2018-202 …
Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of
Blepharitis Treatment Market Opportunity Analysis, 2018-2026
Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of
Blepharitis Market Display Significant Growth by 2025
Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly
Blepharitis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Blepharitis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Blepharitis - Pipeline Review, H2 2017, provides an overview of the Blepharitis (Ophthalmology) pipeline landscape. Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin,